Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Option Care Health (OPCH) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Option Care Health (OPCH) over the last 15 years, with Q3 2025 value amounting to $309.8 million.

  • Option Care Health's Cash & Equivalents fell 3585.81% to $309.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $309.8 million, marking a year-over-year decrease of 3585.81%. This contributed to the annual value of $412.6 million for FY2024, which is 1998.44% up from last year.
  • As of Q3 2025, Option Care Health's Cash & Equivalents stood at $309.8 million, which was down 3585.81% from $198.8 million recorded in Q2 2025.
  • In the past 5 years, Option Care Health's Cash & Equivalents ranged from a high of $483.0 million in Q3 2024 and a low of $109.4 million during Q1 2021
  • Moreover, its 5-year median value for Cash & Equivalents was $255.5 million (2022), whereas its average is $269.9 million.
  • In the last 5 years, Option Care Health's Cash & Equivalents skyrocketed by 14633.95% in 2022 and then plummeted by 4724.52% in 2025.
  • Option Care Health's Cash & Equivalents (Quarter) stood at $119.4 million in 2021, then soared by 146.34% to $294.2 million in 2022, then rose by 16.88% to $343.8 million in 2023, then increased by 19.98% to $412.6 million in 2024, then fell by 24.9% to $309.8 million in 2025.
  • Its last three reported values are $309.8 million in Q3 2025, $198.8 million for Q2 2025, and $171.4 million during Q1 2025.